Avanafil, commonly known for treating erectile dysfunction, is being explored for its potential benefits in managing Parkinson's Disease. Recent research suggests Avanafil may offer neuroprotective effects that could ease Parkinson's symptoms. While still in early stages, this unexpected application raises hopes for new treatment avenues. By delving into this line of investigation, scientists aim to provide more options for those affected by Parkinson's. Understanding Avanafil's mechanisms could transform approaches to neurodegenerative diseases.